| Symbol |
Name |
|
AATF
|
apoptosis antagonizing transcription factor
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACTN4
|
actinin, alpha 4
|
|
AFP
|
alpha-fetoprotein
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
AMER1
|
APC membrane recruitment protein 1
|
|
AMH
|
anti-Mullerian hormone
|
|
APC
|
adenomatous polyposis coli
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ARHGAP24
|
Rho GTPase activating protein 24
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATG4B
|
autophagy related 4B, cysteine peptidase
|
|
ATN1
|
atrophin 1
|
|
BAALC
|
brain and acute leukemia, cytoplasmic
|
|
BASP1
|
brain abundant, membrane attached signal protein 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BLCAP
|
bladder cancer associated protein
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRINP1
|
bone morphogenetic protein/retinoic acid inducible neural-specific 1
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
CAT
|
catalase
|
|
CCN2
|
cellular communication network factor 2
|
|
CCND1
|
cyclin D1
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD34
|
CD34 molecule
|
|
CD38
|
CD38 molecule
|
|
CD99
|
CD99 molecule
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN3
|
cyclin-dependent kinase inhibitor 3
|
|
CIB2
|
calcium and integrin binding family member 2
|
|
CITED1
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1
|
|
CORO1A
|
coronin, actin binding protein, 1A
|
|
CRABP2
|
cellular retinoic acid binding protein 2
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNA3
|
catenin (cadherin-associated protein), alpha 3
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTR9
|
CTR9, Paf1/RNA polymerase II complex component
|
|
DES
|
desmin
|
|
DGCR8
|
DGCR8 microprocessor complex subunit
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIS3L2
|
DIS3 like 3'-5' exoribonuclease 2
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
E2F3
|
E2F transcription factor 3
|
|
EFS
|
embryonal Fyn-associated substrate
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EGR2
|
early growth response 2
|
|
ELP4
|
elongator acetyltransferase complex subunit 4
|
|
EMG1
|
EMG1 N1-specific pseudouridine methyltransferase
|
|
EPHB2
|
EPH receptor B2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ESR1
|
estrogen receptor 1
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EYA1
|
EYA transcriptional coactivator and phosphatase 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGF3
|
fibroblast growth factor 3
|
|
FIBP
|
fibroblast growth factor (acidic) intracellular binding protein
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLII
|
flightless I homolog (Drosophila)
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FRS2
|
fibroblast growth factor receptor substrate 2
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FXR1
|
fragile X mental retardation, autosomal homolog 1
|
|
FZD1
|
frizzled class receptor 1
|
|
FZD5
|
frizzled class receptor 5
|
|
FZD7
|
frizzled class receptor 7
|
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GLI1
|
GLI family zinc finger 1
|
|
GPC3
|
glypican 3
|
|
HACE1
|
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1
|
|
HBB
|
hemoglobin, beta
|
|
HDAC5
|
histone deacetylase 5
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNRNPL
|
heterogeneous nuclear ribonucleoprotein L
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IL2
|
interleukin 2
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
INTS2
|
integrator complex subunit 2
|
|
IRF8
|
interferon regulatory factor 8
|
|
JAG1
|
jagged 1
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDR
|
kinase insert domain receptor
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LMO1
|
LIM domain only 1 (rhombotin 1)
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LUZP2
|
leucine zipper protein 2
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MBTPS1
|
membrane-bound transcription factor peptidase, site 1
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MIA
|
melanoma inhibitory activity
|
|
MIB1
|
mindbomb E3 ubiquitin protein ligase 1
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MLH1
|
mutL homolog 1
|
|
MRC1
|
mannose receptor, C type 1
|
|
MSH6
|
mutS homolog 6
|
|
MSX1
|
msh homeobox 1
|
|
MTDH
|
metadherin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
NAP1L4
|
nucleosome assembly protein 1-like 4
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCKIPSD
|
NCK interacting protein with SH3 domain
|
|
NDC80
|
NDC80 kinetochore complex component
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NES
|
nestin
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFR
|
nerve growth factor receptor
|
|
NKX6-1
|
NK6 homeobox 1
|
|
NNAT
|
neuronatin
|
|
NOTCH1
|
notch 1
|
|
NPHP1
|
nephronophthisis 1 (juvenile)
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPN1SW
|
opsin 1 (cone pigments), short-wave-sensitive
|
|
OSR1
|
odd-skipped related transciption factor 1
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PAX2
|
paired box 2
|
|
PAX3
|
paired box 3
|
|
PAX5
|
paired box 5
|
|
PAX6
|
paired box 6
|
|
PAX8
|
paired box 8
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PFN1
|
profilin 1
|
|
PHB
|
prohibitin
|
|
PHF2
|
PHD finger protein 2
|
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1
|
|
PHLDA2
|
pleckstrin homology-like domain, family A, member 2
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PIAS4
|
protein inhibitor of activated STAT, 4
|
|
PIEZO1
|
piezo-type mechanosensitive ion channel component 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PKHD1
|
polycystic kidney and hepatic disease 1 (autosomal recessive)
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PMEL
|
premelanosome protein
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
PODXL
|
podocalyxin-like
|
|
PON1
|
paraoxonase 1
|
|
POU6F2
|
POU class 6 homeobox 2
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
|
PPP1R2P9
|
protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 9
|
|
PPP2R1A
|
protein phosphatase 2, regulatory subunit A, alpha
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRM1
|
protamine 1
|
|
PRTN3
|
proteinase 3
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTN
|
pleiotrophin
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPA
|
protein phosphatase 2 phosphatase activator
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
QPRT
|
quinolinate phosphoribosyltransferase
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF7
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7
|
|
RB1
|
retinoblastoma 1
|
|
RBBP7
|
retinoblastoma binding protein 7
|
|
RBP2
|
retinol binding protein 2, cellular
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
REN
|
renin
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RIN1
|
Ras and Rab interactor 1
|
|
RNF40
|
ring finger protein 40, E3 ubiquitin protein ligase
|
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
|
RPL10
|
ribosomal protein L10
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
SALL1
|
spalt-like transcription factor 1
|
|
SALL2
|
spalt-like transcription factor 2
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SAT2
|
spermidine/spermine N1-acetyltransferase family member 2
|
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SET
|
SET nuclear proto-oncogene
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SIX1
|
SIX homeobox 1
|
|
SIX2
|
SIX homeobox 2
|
|
SIX3
|
SIX homeobox 3
|
|
SLC22A18
|
solute carrier family 22, member 18
|
|
SLC38A2
|
solute carrier family 38, member 2
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMR3B
|
submaxillary gland androgen regulated protein 3B
|
|
SNAI2
|
snail family zinc finger 2
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOSTDC1
|
sclerostin domain containing 1
|
|
SRPK1
|
SRSF protein kinase 1
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SRY
|
sex determining region Y
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STIM1
|
stromal interaction molecule 1
|
|
STK11
|
serine/threonine kinase 11
|
|
SYCP3
|
synaptonemal complex protein 3
|
|
TBC1D9
|
TBC1 domain family, member 9 (with GRAM domain)
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TES
|
testin LIM domain protein
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TH
|
tyrosine hydroxylase
|
|
THBS1
|
thrombospondin 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP4
|
TIMP metallopeptidase inhibitor 4
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TRIM28
|
tripartite motif containing 28
|
|
TRIM37
|
tripartite motif containing 37
|
|
TRIP13
|
thyroid hormone receptor interactor 13
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSG101
|
tumor susceptibility 101
|
|
USP18
|
ubiquitin specific peptidase 18
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
WFDC1
|
WAP four-disulfide core domain 1
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WT1
|
Wilms tumor 1
|
|
WTIP
|
Wilms tumor 1 interacting protein
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
ZFPM2
|
zinc finger protein, FOG family member 2
|
